Financial Wire

Most Firms, Households See The Iran War Driving Inflation Up, But Not By Enough for a Bank of Canada Response, Says Desjardins

-- While shorter-term inflation expectations understandably rose as a result of the Middle East conflict, longer-term expectations remained largely anchored, even for those who responded to the surveys after the spike in global oil prices, said Desjardins following Monday's release of the Bank of Canada Q1 business (BOS) and consumer surveys (CSCE).

With companies anticipating a pullback in household discretionary spending, many firms say they will have even more trouble passing on the higher input costs, noted the bank.

On that front, consumers across the country expect the net impact of higher global oil prices to be negative for the Canadian economy, with many households having reduced plans for spending in response, Desjardins pointed out.

So, while the evolution of inflation expectations still merits close monitoring, central bankers face some stark trade-offs in terms of a fragile economy, added Desjardins.

With limited information in hand, the bank expects the BoC will report next week that it is still too early to decide whether any action will ultimately be warranted. That said, Desjardins believes that policymakers will leave rates unchanged for the remainder of the year even if oil prices remain elevated for another few weeks.

Many of the other responses to survey questions appear to have been submitted before the outbreak of war in the Middle East. As a result, they are now "stale" and convey less signal, according to the bank.

Related Articles

Australia

Axcelis Technologies Shares Rise After Upgrade From B. Riley

Axcelis Technologies (ACLS) shares were up 8.6% in afternoon trading on Monday after B. Riley upgraded the company's stock to buy from neutral and raised the price target to $150 from $91.Trading volume stood at around 809,000 shares, roughly the same number as the stock's daily average.Price: $128.52, Change: $+9.79, Percent Change: +8.25%

$ACLS
Australia

Argus Cuts Abbott Laboratories' Price Target to $125 From $140

Abbott Laboratories (ABT) has an average rating of overweight and mean price target of $120.48, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $96.06, Change: $-0.75, Percent Change: -0.77%

$ABT
Mining & Metals

NevGold Upsizes Brokered Private Placement Financing to up to Around C$42.2 Million

NevGold (NAU.V) on Monday said it is upsizing best-efforts private placement of shares to $42.2 million, up from its original $25-million target.The company said it will now look to place 22.2 million shares priced of C$1.90 each.The company plans to use proceeds for advancing its Limousine Butte antimony-gold project in Nevada, the Nutmeg Mountain gold project in Idaho, and for working capital and general corporate purposes.The company's shares were last seen up $0.04 to $2.14 on the TSX Venture Exchange.Price: $2.16, Change: $+0.06, Percent Change: +2.86%

$NAU.V